MRC(MRC)
MRC
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $3.30B | $3.31B | $3.45B | $3.60B |
| Low | $3.22B | $3.26B | $3.37B | $3.52B |
| High | $3.35B | $3.36B | $3.51B | $3.66B |
| EBITDA Avg | $75M | $75M | $78M | $82M |
| Low | $73M | $74M | $76M | $80M |
| High | $76M | $76M | $79M | $83M |
| EBIT Avg | $28M | $28M | $29M | $30M |
| Low | $27M | $27M | $28M | $29M |
| High | $28M | $28M | $29M | $31M |
| Net Income Avg | $92M | $98M | $118M | $139M |
| Low | $91M | $96M | $114M | $134M |
| High | $96M | $101M | $120M | $141M |
| EPS Avg | $1.09 | $1.14 | $1.36 | $1.60 |
| Low | $1.05 | $1.11 | $1.32 | $1.55 |
| High | $1.11 | $1.16 | $1.39 | $1.63 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $891M | $825M |
| Low | $891M | $825M |
| High | $891M | $825M |
| EBITDA Avg | $20M | $19M |
| Low | $20M | $19M |
| High | $20M | $19M |
| EBIT Avg | $7M | $7M |
| Low | $7M | $7M |
| High | $7M | $7M |
| Net Income Avg | $34M | $26M |
| Low | $34M | $26M |
| High | $34M | $26M |
| EPS Avg | $0.40 | $0.31 |
| Low | $0.40 | $0.31 |
| High | $0.40 | $0.31 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |